Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Atypical Chronic Myeloid Leukemia: Where Are We Now?

International journal of molecular sciences - 18 Sept 2020

Crisà Elena, Nicolosi Maura, Ferri Valentina, Favini Chiara, Gaidano Gianluca, Patriarca Andrea

Abstract excerpt

Atypical chronic myeloid leukemia, BCR-ABL1 negative (aCML) is a rare myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) with a high rate of transformation to acute myeloid leukemia, and poor survival. Until now, the diagnosis has been based on morphological grounds only, possibly making the real frequency of the disease underestimated. Only recently, new insights in the molecular biology of MDS/MPN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to MAP Kinase Signaling System

Share to Molecular Targeted Therapy

Share to Mutation

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 32962122
DOI: 10.3390/ijms21186862
PMCID: PMC7555965

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Atypical Chronic Myeloid Leukemia: Where Are We Now?PMID 32962122Read ↗

Atypical CML: diagnosis and treatment.Semantic proximity Read ↗

Atypical chronic myeloid leukemia: a rare entity with management challenges.Semantic proximity Read ↗

Current and evolving understanding of atypical chronic myeloid leukemia.Semantic proximity Read ↗

Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.Semantic proximity Read ↗

Mutations in chronic myelomonocytic leukemia and their prognostic relevance.Semantic proximity Read ↗

Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid LeukemiaSemantic proximity Read ↗

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.Semantic proximity Read ↗

Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Semantic proximity Read ↗

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.Semantic proximity Read ↗

Updates in molecular genetics of acute myeloid leukemia.Semantic proximity Read ↗

Myeloid malignancies: mutations, models and management.Semantic proximity Read ↗

Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.